These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 7542579

  • 1. Bone marrow and serum connective tissue polypeptides in idiopathic myelofibrosis.
    Reilly JT, Brindley L, Kay M, Fielding S, Kennedy A, Dolan G, Smith A.
    Clin Lab Haematol; 1995 Mar; 17(1):35-9. PubMed ID: 7542579
    [Abstract] [Full Text] [Related]

  • 2. Bone marrow stroma in idiopathic myelofibrosis and other haematological diseases. An immunohistochemical study.
    Lisse I, Hasselbalch H, Junker P.
    APMIS; 1991 Feb; 99(2):171-8. PubMed ID: 2001283
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Immunohistochemical distribution of collagens type I, III, IV and VI, of undulin and of tenascin in oral fibrous hyperplasia.
    Becker J, Schuppan D, Müller S.
    J Oral Pathol Med; 1993 Nov; 22(10):463-7. PubMed ID: 7510338
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Endothelial cell proliferation in myelofibrosis.
    Reilly JT, Nash JR, Mackie MJ, McVerry BA.
    Br J Haematol; 1985 Aug; 60(4):625-30. PubMed ID: 3927969
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Tenascin immunoreactivity in normal and pathological bone marrow.
    Soini Y, Kamel D, Apaja-Sarkkinen M, Virtanen I, Lehto VP.
    J Clin Pathol; 1993 Mar; 46(3):218-21. PubMed ID: 7681854
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Appearance of the myofibroblastic phenotype in Dupuytren's disease is associated with a fibronectin, laminin, collagen type IV and tenascin extracellular matrix.
    Berndt A, Kosmehl H, Katenkamp D, Tauchmann V.
    Pathobiology; 1994 Mar; 62(2):55-8. PubMed ID: 7524526
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Basement membrane and extracellular interstitial matrix components in bladder neoplasia--evidence of angiogenesis.
    Deen S, Ball RY.
    Histopathology; 1994 Nov; 25(5):475-81. PubMed ID: 7532615
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Distribution of tenascin in healing incision, excision and laser wounds.
    Luomanen M, Virtanen I.
    J Oral Pathol Med; 1993 Jan; 22(1):41-5. PubMed ID: 7678297
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.